Document Classification

Section Type: RESULTS

Text: Before treatment, the levels of ET-1, IL-6 and IL-10 levels were significantly higher and NO was significantly lower in the patients with coronary heart disease than those in the normal group (90. 7 + / - 12. 7 ng/L vs 41. 8 + / - 13. 5 ng/L, 9. 17 + / - 0. 18 ng/L vs 1. 10 + / - 0. 08 ng/L, 1. 94 + / - 0. 26 ng/L vs 1. 09 + / - 0. 06 ng/L, and 92. 2 + / - 17. 7 micromol/L vs 124. 5 + / - 27. 2 micromol/L ; all P < 0. 05), with no significant differences in the levels of ET-1, NO, IL-6 and IL-10 between the treatment group and the control group (P > 0. 05) ; After treatment, ET-1 and IL-6 significantly decreased in the treatment group and the control group, and NO increased in the treatment group ; And IL-6 level was significantly lower and NO level was higher in the treatment group than those in the control group (4. 48 + / - 1. 22 ng/L vs 5. 13 + / - 1. 85 ng/L, 117. 4 + / - 22. 3 micromol/L vs 92. 4 + / - 17. 1 micromol/L ; both P < 0. 05) ; There was a positive correlation between IL-6 and IL-10, and a negative correlation between NO and IL-10 (r = 0. 142, r = -0. 152 ; both P < 0. 05).